Orthokeratology in controlling myopia of children: a meta-analysis of randomized controlled trials.
Care
Children
Myopia
Orthokeratology
Journal
BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802
Informations de publication
Date de publication:
31 Oct 2023
31 Oct 2023
Historique:
received:
15
11
2022
accepted:
13
10
2023
medline:
2
11
2023
pubmed:
1
11
2023
entrez:
1
11
2023
Statut:
epublish
Résumé
Delaying the development and lowering the progression of myopia in children is the focus of current ophthalmology researches. We aimed to evaluate the role of orthokeratology in controlling myopia of children, to provide insights to the clinical treatment and care of children with myopia. Two investigators searched the The Cochrane Library, Embase, Pubmed, China national knowledge infrastructure, China biomedical literature database, WanFang and Weipu databases for randomized controlled trials(RCTs) on the role of orthokeratology in controlling myopia of children up to November 5, 2022. Two researchers independently searched, screened and extracted the studies according to the inclusion and exclusion standards. RevMan5.3 software was used for statistical analysis. A total of 14 RCTs involving 2058 children were included in this meta-analysis. Synthesized outcomes indicated that orthokeratology improved the uncorrected visual acuity(MD = 0.40, 95%CI: 0.05 ~ 0.74), reduced the diopter change(MD=-3.19, 95%CI: -4.42~-1.95), changes of corneal curvature(MD=-3.21, 95%CI: -3.64~-2.79), the length of ocular axis (MD=-0.66, 95%CI: -1.27~-0.06) and amount of ocular axis change(MD=-0.42, 95%CI: -0.64~-0.21) after 1 year of wearing orthokeratology(all P < 0.05). Besides, orthokeratology reduced the diopter change (MD=-3.22, 95%CI: -4.86~-1.58), the length of ocular axis (MD=-1.15, 95%CI: -2.25~-0.06) and the amount of ocular axis change after 2 year of wearing orthokeratology (MD=-0.53, 95%CI: -0.96~-0.11) after 2 year of wearing orthokeratology (all P < 0.05). No publication biases were found amongst the synthesized outcomes (all P > 0.05). Orthokeratology delays the progression of myopia in children, the long-term effects of orthokeratology need further investigations in future studies.
Sections du résumé
BACKGROUND
BACKGROUND
Delaying the development and lowering the progression of myopia in children is the focus of current ophthalmology researches. We aimed to evaluate the role of orthokeratology in controlling myopia of children, to provide insights to the clinical treatment and care of children with myopia.
METHODS
METHODS
Two investigators searched the The Cochrane Library, Embase, Pubmed, China national knowledge infrastructure, China biomedical literature database, WanFang and Weipu databases for randomized controlled trials(RCTs) on the role of orthokeratology in controlling myopia of children up to November 5, 2022. Two researchers independently searched, screened and extracted the studies according to the inclusion and exclusion standards. RevMan5.3 software was used for statistical analysis.
RESULTS
RESULTS
A total of 14 RCTs involving 2058 children were included in this meta-analysis. Synthesized outcomes indicated that orthokeratology improved the uncorrected visual acuity(MD = 0.40, 95%CI: 0.05 ~ 0.74), reduced the diopter change(MD=-3.19, 95%CI: -4.42~-1.95), changes of corneal curvature(MD=-3.21, 95%CI: -3.64~-2.79), the length of ocular axis (MD=-0.66, 95%CI: -1.27~-0.06) and amount of ocular axis change(MD=-0.42, 95%CI: -0.64~-0.21) after 1 year of wearing orthokeratology(all P < 0.05). Besides, orthokeratology reduced the diopter change (MD=-3.22, 95%CI: -4.86~-1.58), the length of ocular axis (MD=-1.15, 95%CI: -2.25~-0.06) and the amount of ocular axis change after 2 year of wearing orthokeratology (MD=-0.53, 95%CI: -0.96~-0.11) after 2 year of wearing orthokeratology (all P < 0.05). No publication biases were found amongst the synthesized outcomes (all P > 0.05).
CONCLUSIONS
CONCLUSIONS
Orthokeratology delays the progression of myopia in children, the long-term effects of orthokeratology need further investigations in future studies.
Identifiants
pubmed: 37907884
doi: 10.1186/s12886-023-03175-x
pii: 10.1186/s12886-023-03175-x
pmc: PMC10617145
doi:
Types de publication
Meta-Analysis
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
441Informations de copyright
© 2023. The Author(s).
Références
JAMA Ophthalmol. 2022 Feb 01;140(2):162-169
pubmed: 34989764
Ophthalmic Physiol Opt. 2022 Mar;42(2):345-357
pubmed: 35019150
Ophthalmic Physiol Opt. 2022 Jul;42(4):786-796
pubmed: 35499112
Indian J Ophthalmol. 2022 Sep;70(9):3366-3368
pubmed: 36018122
Children (Basel). 2022 Mar 09;9(3):
pubmed: 35327754
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
BMC Ophthalmol. 2022 Jun 4;22(1):248
pubmed: 35658918
Front Public Health. 2022 Oct 13;10:993728
pubmed: 36324441
Eye Contact Lens. 2020 May;46(3):141-146
pubmed: 31361656
J Formos Med Assoc. 2022 Dec;121(12):2490-2500
pubmed: 35688780
Acta Ophthalmol. 2022 Mar;100(2):175-182
pubmed: 34233094
Br J Ophthalmol. 2022 Aug;106(8):1104-1109
pubmed: 33712479
Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1411-1416
pubmed: 28253404
Front Public Health. 2022 Jun 22;10:901480
pubmed: 35812505
PLoS One. 2022 Feb 3;17(2):e0263335
pubmed: 35113922
Ophthalmic Physiol Opt. 2022 Mar;42(2):327-334
pubmed: 34866209
Int J Gen Med. 2022 Apr 18;15:4151-4162
pubmed: 35465306
Eye Contact Lens. 2022 Mar 1;48(3):100-104
pubmed: 34860723
J Ophthalmol. 2022 Jun 14;2022:1004977
pubmed: 35747583
Optom Vis Sci. 2013 Jun;90(6):530-9
pubmed: 23645372
Front Public Health. 2022 May 10;10:897600
pubmed: 35619815
BMC Ophthalmol. 2022 Feb 15;22(1):76
pubmed: 35164702
BMC Public Health. 2022 Aug 30;22(1):1637
pubmed: 36038863
Eye (Lond). 2022 May;36(5):921-929
pubmed: 34645966
Int J Environ Res Public Health. 2022 Jul 22;19(15):
pubmed: 35897282
Front Pediatr. 2022 Jan 18;9:773484
pubmed: 35118029
Int J Ophthalmol. 2022 Jan 18;15(1):113-118
pubmed: 35047365
Zhonghua Yan Ke Za Zhi. 2022 Nov 11;58(11):907-913
pubmed: 36348527
J Clin Med. 2022 Apr 20;11(9):
pubmed: 35566423
Clin Exp Optom. 2023 Nov;106(8):836-844
pubmed: 36045001
Front Public Health. 2022 Jul 25;10:924566
pubmed: 35958863
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Invest Ophthalmol Vis Sci. 2012 Oct 11;53(11):7077-85
pubmed: 22969068
Cont Lens Anterior Eye. 2022 Jun;45(3):101538
pubmed: 34802915
Eye Contact Lens. 2022 May 1;48(5):189-193
pubmed: 35333801
J Pers Med. 2022 Feb 14;12(2):
pubmed: 35207766
Int Ophthalmol. 2020 Jan;40(1):255-265
pubmed: 31916062